[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.247.205. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
February 1972

Topically Administered Fluorouracil in Psoriasis

Author Affiliations

Osaka, Japan

From the Department of Dermatology, Osaka (Japan) City University Medical School (Dr. Tsuji), and the Division of Dermatology, Osaka (Japan) Kaisei Hospital (Dr. Sugai).

Arch Dermatol. 1972;105(2):208-212. doi:10.1001/archderm.1972.01620050022003
Abstract

In 13 patients with psoriasis, fluorouracil at 5% concentration in ointment base was applied daily to psoriatic lesions under the occlusive dressings. The treated lesions became completely erosive at seven to nine trials, preceded by a burning sensation and accompanied by pain. A rapid epithelization was seen soon after stopping the fluorouracil treatment. Thus, all the patients showed a complete clearing of the lesions treated with the antimetabolite, and the psoriasis has not recurred during the observation period ranging from 6 to 13 months, except in a patient in whom small psoriatic lesions recurred after 11 months. The characteristic features of histological response of psoriatic lesions to fluorouracil was the destructive degeneration of the epidermal cells, mainly edema and vacuolated degeneration, leading to necrobiosis. No systemic toxicity was found in this series of patients.

×